Allergy and Immunology · Greenville, PA
NPI
1881660249
Since 2006
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
59 W Main St
Greenville, PA, 16125
Phone (724) 588-7531
Groups this clinician bills Medicare through
Medicare paid, 2024
$134K
8,286 services
Medicare patients, 2024
230
Average age 70
Drug cost, 2024
$1.3M
768 prescriptions
Company payments, 2025
$2,540
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Francisco J Cano was code 95165 (treatment - miscellaneous), 2,222 times for 113 patients. In total Francisco J Cano billed 8,286 services in 21 codes, and Medicare paid $134K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95165 Treatment - Miscellaneous | Office | 2,222 | 113 | $9.38 | $21K |
| 95117 Treatment - Miscellaneous | Office | 1,566 | 91 | $7.64 | $12K |
| 95004 Test - Miscellaneous | Office | 1,444 | 41 | $2.43 | $3,514 |
| 95115 Treatment - Miscellaneous | Office | 934 | 53 | $6.31 | $5,897 |
| 95148 Treatment - Miscellaneous | Office | 544 | 22 | $66.72 | $36K |
| 95024 Test - Miscellaneous | Office | 475 | 38 | $5.61 | $2,665 |
| 99213 Office E&M - Established | Office | 88 | 76 | $59.30 | $5,218 |
| 99203 Office E&M - New | Office | 30 | 30 | $77.95 | $2,339 |
| 94060 Pulmonary Function Testing | Office | 26 | 24 | $25.22 | $656 |
| 99204 Office E&M - New | Office | 23 | 23 | $109.55 | $2,520 |
By year: 2022 $121K for 8,438 services; 2023 $148K for 9,751 services; 2024 $134K for 8,286 services.
Medicare prescription drug claims, 2024
In 2024, the drug Francisco J Cano prescribed most often to Medicare patients was Fluticasone Propionate, with 66 prescriptions and refills. In total Francisco J Cano wrote 768 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fluticasone Propionate Generic | 66 | 111 | 20 | $876 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 53 | 54 | 24 | $1,652 |
| Montelukast Sodium Generic | 53 | 117 | 15 | $660 |
| Breo Ellipta Fluticasone/Vilanterol | 50 | 58 | 13 | $22K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 48 | 60 | 13 | $38K |
| Dupixent Pen Dupilumab | 47 | 47 | Under 11 | $226K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 34 | 34 | Under 11 | $3,213 |
| Levocetirizine Dihydrochloride Generic | 30 | 54 | Under 11 | $236 |
| Prednisone Generic | 30 | 32 | 28 | $63.53 |
| Symbicort Budesonide/Formoterol Fumarate | 29 | 37 | Under 11 | $8,059 |
| Ipratropium Bromide Generic | 28 | 68 | 11 | $697 |
| Epinephrine Generic | 24 | 24 | 24 | $4,717 |
| Triamcinolone Acetonide Generic | 21 | 21 | 11 | $187 |
| Arnuity Ellipta Fluticasone Furoate | 21 | 21 | Under 11 | $4,308 |
| Azelastine Hcl Generic | 20 | 24 | Under 11 | $401 |
Brand drugs: 396 claims; generic drugs: 372 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Francisco J Cano $2,540 ($2,540 in general payments such as food, travel and fees) from 16 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $410.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 13 | $410 |
| Genzyme Corporation SNY | 15 | $342 |
| GlaxoSmithKline, LLC. GSK | 20 | $314 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $216 |
| Amgen Inc. AMGN | 5 | $211 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $181 |
| Regeneron Healthcare Solutions, Inc. REGN | 7 | $143 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 1 | $125 |
| CSL Behring CSL.AX | 5 | $123 |
| Genentech USA, Inc. ROG.SW | 5 | $118 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.